BIOMERIEUX (P.S.) O.N. revenue for the last year amounted to 3.98 B EUR, the most of which — 33.74 B EUR — came from its highest performing source at the moment, Clinical Applications, the year earlier bringing 3.10 B EUR. The greatest contribution to the revenue figure was made by Americas — last year it brought BIOMERIEUX (P.S.) O.N. 2.05 B EUR, and the year before that — 1.85 B EUR.